tiprankstipranks
Trending News
More News >
Vir Biotechnology (VIR)
NASDAQ:VIR
US Market

Vir Biotechnology (VIR) Balance Sheet

Compare
1,516 Followers

Vir Biotechnology Balance Sheet

Vir Biotechnology's total assets for Q4 2025 were $1.00B, a decrease of -1.63% from the previous quarter. VIR total liabilities were $237.55M for the fiscal quarter, a 6.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 1.00B$ 1.40B$ 1.92B$ 2.80B$ 1.95B
Total Liabilities
$ 237.55M$ 248.43M$ 328.82M$ 724.13M$ 522.42M
Total Equity Gross Minority
$ 765.28M$ 1.15B$ 1.59B$ 2.08B$ 1.43B
Other Metrics
Currency in USD

Vir Biotechnology Debt to Assets